Binex , Abdi Ibrahim sign deal to sell Remicade biosimiar
Published: 2012-09-24 06:57:00
Updated: 2012-09-24 06:57:00
Binex Pharmaceuticals Co. said Thursday it established a strategic partnership with Abdi Ibrahim Pharmaceuticals to sell its Remicade biosimilar product in Turkey. Remicade is a globally renowned medication for rheumatoid arthritis.
Binex and Abdi Ibrahim will get the approval for sales and ha...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
